10-Q: Mag Magna Q1 2026 Loss, Leadership Change, Going Concern
Quarterly Report
Mag Magna Corp. reported a significant net loss and zero revenue for Q1 2026, following a change in control and management, raising substantial doubt about its ability to continue as a going concern.
Summary
- Reported a net loss of $90,425 for the three months ended July 31, 2025, compared to a net loss of $14,026 for the same period in 2024.
- Generated no revenue for the three months ended July 31, 2025, a significant decrease from $5,293 in the prior year period.
- Operating expenses increased to $90,425 from $19,321, primarily due to professional fees related to the change in management.
- Experienced a change in control on June 4, 2025, with Wang Gang acquiring 77.20% of common stock and assuming all key executive and director roles.
- The former CEO, Oleg Bilinski, forgave $137,000 in related-party loans, which reduced total liabilities and improved stockholders' equity.
- Accumulated deficit increased to $211,449 as of July 31, 2025, from $121,024 as of April 30, 2025.
- Management concluded that disclosure controls and procedures were not effective as of July 31, 2025.
- The company's ability to continue as a going concern is in substantial doubt due to recurring losses and negative cash flows from operations.
Sentiment
Score: 2
Explanation: The company reported zero revenue, a significantly increased net loss, and negative cash flow from operations, raising substantial doubt about its ability to continue as a going concern. While a related-party loan was forgiven, new liabilities to a shareholder emerged, and disclosure controls were deemed ineffective.
Positives
- Related-party loan forgiveness of $137,000 by former CEO Oleg Bilinski, which reduced total liabilities and improved stockholders' equity.
- Reduction in total liabilities from $227,595 at April 30, 2025, to $157,102 at July 31, 2025.
- Improvement in total stockholders' equity (deficit) from $(83,298) to $(36,723).
Negatives
- Zero revenue generated for the three months ended July 31, 2025, a significant decline from $5,293 in the prior year.
- Net loss increased substantially to $90,425 for the quarter, compared to $14,026 in the prior year.
- Operating expenses rose sharply to $90,425, primarily due to professional fees associated with the change in management.
- Net cash used in operating activities increased to $66,507, up from $562 in the prior year.
- Accumulated deficit grew to $211,449, indicating continued unprofitability.
- Management concluded that disclosure controls and procedures were not effective as of July 31, 2025.
- The company has no cash at the end of the period.
Risks
- Substantial doubt about the ability to continue as a going concern due to an accumulated deficit of $211,449, a net loss of $90,425, and negative cash flow from operations of $66,507 for the three months ended July 31, 2025.
- Dependence on generating profitable operations and/or obtaining necessary financing to meet obligations and repay liabilities.
- No assurances that additional funding will be achieved or that future operations will be successful.
- Lack of available capital for sales and marketing activities, which impaired the ability to generate revenues.
- Ineffective disclosure controls and procedures.
Future Outlook
Management intends to finance operating costs over the next twelve months with sales proceeds and related party loans. However, there are no assurances that such additional funding will be achieved or that the company will succeed in its future operations. The company anticipates further losses in the development of its business for the foreseeable future.
Management Comments
- "Our management intends to finance operating costs over the next twelve months with sales proceeds and related party loans."
- "While we believe that we will be successful in obtaining the necessary financing and generating revenue to fund our operations, meet regulatory requirements, and achieve commercial goals, there are no assurances that such additional funding will be achieved and that we will succeed in our future operations."
- "The reason for the lack of sales for Interim 2026 was due to the lack of capital with which to market our services."
- "Operating expenses increased during Interim 2026 primarily due to an increase in professional fees related to the change in management."
- "Our management concluded that our disclosure controls and procedures were not effective as of such date to ensure that information required to be disclosed in the reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in SEC rules and forms."
Industry Context
Mag Magna Corp. operates in the niche market of poultry farming consulting, specifically promoting antibiotic-free methods and leveraging AI for poultry wellness. This aligns with growing consumer demand for sustainable and healthier food production. However, the company's current financial state, marked by zero revenue and significant losses, suggests it is struggling to capitalize on these trends, possibly due to a lack of market penetration or operational capital, which is critical in a competitive agricultural technology space.
Comparison to Industry Standards
- NA
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| President, Chief Executive Officer, Treasurer, Secretary, Director | Oleg Bilinski | Wang Gang | 2025-06-04 | Resignation of Oleg Bilinski and appointment of Wang Gang as part of a change in control. |
| Director | Tomasz Anczok | NA | 2025-06-04 | Resignation of Tomasz Anczok as part of a change in control. |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Change in Control | Wang Gang acquired 77.20% of outstanding common stock, gaining voting control. This led to a complete change in the executive management and board of directors. | 2025-06-04 | Centralized control under a single individual (Wang Gang) as sole director and executive officer. Potential for streamlined decision-making but also increased key-person risk. Disclosure controls and procedures were deemed ineffective post-change. |
| Disclosure Controls and Procedures | Management concluded that disclosure controls and procedures were not effective as of July 31, 2025. | 2025-07-31 | Raises concerns about the accuracy and timeliness of financial reporting and compliance with SEC rules. Requires immediate attention and remediation efforts. |
Legal Proceedings
- No legal proceedings are known to be pending, threatened, or contemplated, and no unsatisfied judgments against the company.
Related Party Transactions
- Former CEO Oleg Bilinski advanced $14,351 and was repaid $6,816 during the three months ended July 31, 2025.
- Oleg Bilinski forgave $137,000 in related-party loans owed to him by the company, effective June 4, 2025.
- The balance owed to Oleg Bilinski was $92,462 as of July 31, 2025.
- A shareholder advanced $58,972 on behalf of the company, with this balance owed as of July 31, 2025.
Stakeholder Impact
- Shareholders: Significant dilution of control for previous shareholders not involved in the change of control. Existing shareholders face substantial doubt about the company's going concern status and continued losses. The loan forgiveness is a positive for equity, but new shareholder debt is a concern.
- Employees: Not explicitly mentioned, but the change in management could impact future employment stability or direction.
- Customers: Zero revenue suggests a lack of current customer engagement or inability to market services effectively, potentially impacting future customer base.
- Suppliers/Creditors: The company's going concern status and reliance on related-party financing pose risks to creditors. The reduction in related-party debt is positive, but new shareholder debt adds to liabilities.
- Regulatory Authorities: Ineffective disclosure controls and procedures will likely draw scrutiny and require remediation.
Next Steps
- Generate profitable operations.
- Obtain necessary financing to meet obligations and repay liabilities.
- Improve sales and marketing activities to generate revenue.
- Address the ineffectiveness of disclosure controls and procedures.
Key Dates
| Date | Description |
|---|---|
| 2021-09-20 | Company incorporated under the laws of the State of Wyoming. |
| 2022-11-15 | Patent License and Assignment Agreement signed with Ipax LLC. |
| 2024-02-27 | Application Programming Interface (API) Development Agreement entered into. |
| 2024-06-01 | Company introduced Poultry Wellness Guide API on website and began selling Subscription Plans for API services (since June 2024). |
| 2024-07-31 | End of three-month period for comparative financial statements. |
| 2024-11-01 | FASB issued ASU 2024-03 (November 2024). |
| 2025-04-30 | Company's fiscal year-end and comparative balance sheet date. |
| 2025-06-04 | Change in control occurred; Wang Gang acquired control shares, Oleg Bilinski and Tomasz Anczok resigned, Wang Gang appointed Sole Director and Executive Officer. |
| 2025-07-31 | End of current quarterly reporting period. |
| 2025-11-13 | Latest practicable date for common shares outstanding (5,829,047 shares). |
| 2025-11-14 | Date of signing of the 10-Q report and certifications. |
| 2026-12-15 | Effective date for ASU 2024-03 for annual reporting periods beginning after this date. |
Recommendation
strong sellThe company reported zero revenue, a substantial increase in net loss, and negative cash flow from operations, leading to an explicit 'going concern' warning. Despite a related-party loan forgiveness, the overall financial health is severely distressed, and disclosure controls are ineffective. The lack of capital for marketing and sales suggests a fundamental operational challenge. These factors indicate a high risk of business failure and significant downside for investors.
Keywords
Poultry farming, Antibiotic-free, API, Consulting services, SEC filing, 10-Q, Financial results, Going concern, Change in control, Wang Gang, Oleg Bilinski, Mag Magna Corp, Agricultural technology, Biotechnology
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.